Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $12.93 Million |
|---|---|
| Enterprise Value | $10.56 Million |
| Earnings per Share | $-8.81 |
| Beta | 1.5 |
| Outstanding Shares | 7,472,200 |
| P/E Ratio | -0.53 |
|---|---|
| PEG | 1.12 |
| Price to Sales | - |
| Price to Book Ratio | 0.87 |
| Enterprise Value to Revenue | 124.71 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 6.97%▼ 2.56% |
|---|---|
| Total Invested | $2.36M▼ 11.13% |
| Investors Holding | 19▼ 9.00% |
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neuro...